Latest / Science Behind the Glass: illuminating the human side / Venom & Epilepsy: Can a Spider Save a Human Life? with Dr Dani Rojas
Transcript
- 0:01Who are the characters behind science? This is
- 0:04Science Behind the Glass, illuminating the human
- 0:06side. In this podcast, we unveil the human side
- 0:11of laboratories and science. Scientists share
- 0:14personal experiences, and we discuss their meanings
- 0:17from different perspectives and fields of research.
- 0:23Disclaimer, this is a translated version using
- 0:26AI voice for the guest. Welcome to Science Behind
- 0:29the Glass, illuminating the human side. Today,
- 0:31we travel from the tropical forests of Costa
- 0:33Rica to high -tech laboratories in Australia
- 0:35to meet a scientist who has turned her childhood
- 0:38curiosity into a way of life. Our guest, Dr.
- 0:43Dani Rojas Asofeipa, grew up surrounded by biodiversity,
- 0:47fascinated by tiny creatures most people wouldn't
- 0:51even notice, scorpions, spiders, insects. What
- 0:54looked like a mere childhood hobby became a scientific
- 0:57career that now seeks something incredible. medicines
- 1:01hidden in venoms. From a tropical scorpion to
- 1:04an Australian spider, Dani has followed the trail
- 1:07of compounds that could change the lives of people
- 1:10with epilepsy or heart problems. But her story
- 1:13isn't just about science. It's about migration,
- 1:16adaptation, and carving out a place as a Latin
- 1:19American woman in global research. How does venom
- 1:22become a cure? And what does it take to grow
- 1:25the world pursuing an idea? That's the story
- 1:27we're telling today. Dani, thank you so much
- 1:30for accepting this invitation. It's a pleasure
- 1:32to have you here. Hello. Thank you very much
- 1:35for the invitation. Yes, it's really lovely.
- 1:38I'm very excited. This is my first podcast. To
- 1:41begin with, tell us a bit about your childhood
- 1:44in Costa Rica. How did your curiosity for small
- 1:47animals like spiders, insects, bugs start? I
- 1:50think my family had a lot to do with it. I'm
- 1:53the youngest of five siblings. My brothers and
- 1:55sisters are much older than I am. So I always
- 1:58had a lot of freedom. My parents always let me
- 2:00wander, explore, do things, and I think that
- 2:03fostered a lot of curiosity in me. When I was
- 2:06little, I was always asking questions. I remember
- 2:08asking, what does this mean? A lot. Sometimes
- 2:11adults didn't know how to answer. A few things
- 2:14about my childhood. I loved studying. I really
- 2:17liked school, strange, right? And I always loved
- 2:20learning. Maybe my focus on animals comes mainly
- 2:22from my parents, and my family in general. On
- 2:26weekends we'd go to national parks or city parks.
- 2:28We'd ride horses, visit volcanoes, and on the
- 2:31weekends we didn't do those things, we'd go to
- 2:34my grandparents' house. My maternal grandmother's
- 2:37house was deep in the countryside. You couldn't
- 2:39reach it by car. You had to park, walk along
- 2:42a little trail, cross a few rivers, and then
- 2:45arrive. I remember my cousins and I sometimes
- 2:47went on excursions, to the river to look for
- 2:50things, to see what we could find. All of that
- 2:52definitely influenced my decision to study biology
- 2:55later on. I liked all animals and nature, but
- 2:58I don't feel that as a small child I was fascinated
- 3:01by something specific. That came later. I think
- 3:04the scientific curiosity really blossomed once
- 3:06I was in university. That's a very interesting
- 3:09point and we have seen it in several interviews.
- 3:13Curiosity is the common thread and starting point
- 3:15for most scientists. It's great and it pushes
- 3:19you to explore new things. In your case, what
- 3:22do you think sparked your interest in venom?
- 3:25I think it was my master's degree. I finished
- 3:28my biology bachelor's and then did a master's
- 3:30in biomedical sciences. I started that master's
- 3:33because I loved biochemistry, but I felt I was
- 3:36missing pure biology. By chance, there was an
- 3:38opportunity to work on a project at the Claudio
- 3:41Miro Picado Institute, which is internationally
- 3:43renowned for producing snake antivenoms. The
- 3:46project was very new. They said, we have some
- 3:49scorpion venoms. and we need someone who wants
- 3:51to start working with them. And that's how I
- 3:54got into venoms. Before that I'd worked with
- 3:56spiders, mainly doing what's called neuroethology,
- 3:59studying behavior from the nervous system perspective.
- 4:02In my undergrad I worked with a researcher at
- 4:04the University of Costa Rica. We wanted to understand
- 4:07biochemical changes in the brains of spiders,
- 4:10a species that was being parasitized by a wasp.
- 4:13I dissected spider brains, which were super tiny.
- 4:16So I started with spiders and then moved to the
- 4:19master's project. Pure chance, but I loved it.
- 4:22Since then, there's been no turning back. Oh,
- 4:24exciting. Can I know which spider species was
- 4:29it? No, it was Cyclosa. Wow, that's very exciting.
- 4:34How do you evaluate the changes in the spider's
- 4:37nervous system? Mainly with imaging, using antibodies
- 4:40to detect changes in the neurochemistry of what
- 4:42we call neuromodulators. And did you find differences
- 4:45when they were parasitized? Yes, there were certain
- 4:48differences. I don't remember all the details
- 4:50now. It was quite a few years ago. But yes, some
- 4:53neurochemicals were being altered. And can you
- 4:56explain in very simple words for our listeners,
- 4:59as if you were explaining to a child, why you
- 5:02work with peptides and what those peptides are
- 5:07and why they are so important in the research
- 5:10you are doing? Peptides are like tiny proteins
- 5:13or little pieces of proteins. These peptides
- 5:16can modulate or change the activity of cells.
- 5:19Specifically, in my postdoc I'm working with
- 5:21epilepsy. We're looking for peptides that can
- 5:24modulate neuronal activity. And you do this with
- 5:27venom peptides, right? Yes, exactly. Venoms in
- 5:31general are very complex. Spider venoms too.
- 5:34And inside them are many of those peptides that
- 5:36spiders use either for defense or mainly to hunt.
- 5:39The idea is to see whether any of these peptides,
- 5:42small proteins that evolution has fine -tuned
- 5:44to act on the nervous system of their prey, can
- 5:47be repurposed. or at least studied, to understand
- 5:50how they might affect the human nervous system.
- 5:52So we have projects not only on epilepsy but
- 5:54also on pain and heart disease. That was my focus
- 5:57during my PhD. That's very interesting. And the
- 6:01animals you are using are Australian species,
- 6:04right? Right now, well, it depends on the project.
- 6:06Some are Australian. In one part of the project,
- 6:09we have venoms from spiders all over the world,
- 6:11and we do a screening. We test many of those
- 6:14venoms to see which one has the activity we're
- 6:16looking for. You were telling us that you began
- 6:19working with these tiny proteins for disease
- 6:22research during your doctorate. What led you
- 6:24to do your PhD in Australia? How did you get
- 6:27there? Had you thought about staying in Costa
- 6:30Rica or perhaps doing a doctorate somewhere else?
- 6:33I ended up here because while writing my master's
- 6:36thesis, I had to read a lot of papers, like any
- 6:39thesis. Whenever I really liked an article, I'd
- 6:42note the author. and it turned out that Professor
- 6:44Glenn King from the Institute for Molecular Bioscience
- 6:47at the University of Queensland was the common
- 6:49denominator. He appeared in every paper. I'd
- 6:52think, I love this it fascinates me. So I looked
- 6:56into his lab and decided to email him. He took
- 6:59a while to reply, but in my message I introduced
- 7:01myself, and said I was working with a scorpion
- 7:04venom at the Clotamiro Picado Institute. He answered,
- 7:07said he knew the institute, and wanted to have
- 7:10a meeting. We met, and honestly when I decided
- 7:12to apply for a PhD I said, it's this PhD or nothing.
- 7:16I applied only for that scholarship, that doctoral
- 7:19program, and nothing else. If it wasn't in that
- 7:22lab, I wasn't going to do a doctorate. No plan
- 7:25B, plan B was, I don't know what I'll do. From
- 7:28the start I set several conditions. It had to
- 7:31be that lab, the venom lab doing drug discovery.
- 7:34It had to be in a beautiful, safe country where
- 7:37the PhD would be relatively short. compared with
- 7:39the US for example, where it can take many years.
- 7:42The doctorate had to be mainly research. I didn't
- 7:45want to depend on teaching to keep my scholarship.
- 7:48I wanted to devote myself 100 % to research.
- 7:51I didn't entirely manage that, because I still
- 7:54did some tutoring and small science -related
- 7:56jobs, but the main focus was research. And a
- 7:59bit outside the science box, I wanted to live
- 8:01somewhere with nice weather. Being a tropical
- 8:03woman, I miss warm beaches. So Queensland ticked
- 8:06all the boxes. Yes, your wish list came true.
- 8:11Completely. How lucky. You had already been working
- 8:14with venoms, right? Why do you focus on spiders?
- 8:18For instance, people have found drugs or active
- 8:22compounds from snake venoms. Why spiders? Aren't
- 8:26the other arthropods candidate? I've always found
- 8:30invertebrates more interesting than vertebrates.
- 8:32I feel invertebrates aren't studied enough. Whereas
- 8:36there's much more research and information on
- 8:38vertebrates, it wasn't about choosing the best
- 8:41venom. It's simply that I like spiders more.
- 8:44Yes, I agree. I'm a bit biased though, but yeah,
- 8:48I love arthropods, especially spiders. Very interesting.
- 8:52You said the research focuses on these small
- 8:55proteins, the peptides. How do you identify these
- 8:59peptides within an animal's venom? Have you already
- 9:03found a promising compound or peptide that looks
- 9:06like it could work for a specific disease? How
- 9:09does that part of the research work? First, you
- 9:13need a target. Usually these cellular targets
- 9:16are other proteins, large proteins, called ion
- 9:19channels. They let different ions pass through
- 9:22the cell and enable cellular activity. In many
- 9:25diseases, those ion channels are affected. So
- 9:28once we have that target, we want to see which
- 9:31venom acts on it. Often we need the raw venom
- 9:34to start. We go into the field, collect spiders,
- 9:37milk them, that's the term for extracting venom,
- 9:40and once we've got it, we dry it, often repeatedly,
- 9:43and turn it into a powder we can use in various
- 9:46ways. We have cells expressing the ion channels
- 9:49we're targeting and we screen the crude venom,
- 9:51straight from the spider, and run different assays.
- 9:54When we see a positive result for a particular
- 9:57venom, we take that venom and separate it into
- 10:00its main components. There are many laboratory
- 10:03techniques we can use, so we first separate the
- 10:06venom into its individual components. Once we
- 10:09have those many components, we retest them to
- 10:12see which one gives the activity we observed
- 10:14at the start when we applied the whole venom.
- 10:16Okay, assuming we find the ideal one, the next
- 10:20step is to identify the peptide itself. For that
- 10:23we use many tools, bioinformatics, sequencing,
- 10:26and so on. Because peptides are mini -proteins,
- 10:29and proteins and peptides are made of amino acids,
- 10:32we can determine exactly which amino acids make
- 10:35up that peptide. Once we've done that, once we
- 10:38know which peptide it is, we no longer have to
- 10:41go back to the venom. We can produce it in the
- 10:43lab. There are two main ways. One is to make
- 10:47it synthetically in a small machine, and the
- 10:49other is to use bacteria, yeast or other cells
- 10:52by inserting the gene for the peptide. The bacteria
- 10:55express the peptide. basically do the work for
- 10:58us, and then we can purify it. So it means that
- 11:02you don't have to collect more spiders. Exactly.
- 11:05Unless we wanted to keep working with other parts
- 11:08of the venom, what we call other fractions, there's
- 11:11no need. That's really important, because to
- 11:13test a peptide that's super tiny you need a lot
- 11:16of it for all the different analyses. And if
- 11:18that peptide eventually became a candidate for
- 11:21a drug, we'd also have to think about producing
- 11:23it in larger quantities. All of that matters
- 11:26when testing venoms. Whoa, that sounds super
- 11:29impressive. So much work. You also mentioned
- 11:32that you work with brain organoids to test compounds.
- 11:35You are not working with animals, but with these
- 11:38little organs instead. And you make them from
- 11:43humans. Could you explain a bit what is that?
- 11:46What the organoids are? and what is important,
- 11:49and I think that it's great that you use them,
- 11:53but it would be nice if you could explain a little
- 11:56bit to our listeners. For this epilepsy project,
- 11:59many scientists are involved. Here in Australia
- 12:02and internationally, researchers, clinicians,
- 12:04specialists. It's a very big project, and one
- 12:08of our collaborators is responsible for making
- 12:10these organoids. What are organoids? I call them
- 12:13mini -brains. It might sound a bit like science
- 12:16fiction, but that's what they are. Clinicians
- 12:18have patients with epilepsy. These patients give
- 12:21blood samples, and we take the cells from that
- 12:23blood. Then we revert those cells to a primitive
- 12:26state, stem cells. And from those stem cells,
- 12:29we can differentiate neurons that are specific
- 12:31for each patient. And could you expand a bit?
- 12:35What exactly are stem cells? How do they differ
- 12:40from a regular cell? Say, when we cut our cells
- 12:44and the tissue starts to heal. Stem cells are
- 12:47basically cells that don't yet have a defined
- 12:49destiny. Depending on the signals they receive,
- 12:52some can become heart cells, others brain cells,
- 12:55others skin cells and so on. They're like baseline
- 12:58cells without an identity. Because they don't
- 13:00have an identity yet, we can through different
- 13:03mechanisms, tell them to become neurons. If we
- 13:06add different factors, they'll become heart cells.
- 13:08And that's what I worked with during my PhD.
- 13:11Heart cells differentiated from stem cells. This
- 13:14gives us lots of advantages. First, we're working
- 13:17with human cells. It's often very hard to get
- 13:20heart or brain cells from a patient. You need
- 13:22many cells, so having access to these techniques
- 13:25and cell types lets us build very specific models.
- 13:28So in the epilepsy case, as I said, patients
- 13:31give a blood sample, we convert those blood cells
- 13:33into stem cells, and then we basically hack them
- 13:36and tell them, you're going to become a neuron,
- 13:38a brain cell. We do that with a little group
- 13:41of cells, hence the nickname mini -brains, though
- 13:44the correct term is organoids. They're not an
- 13:46organ per se, but a tiny organ -like structure.
- 13:49The big advantage in this project, huge thanks
- 13:52to everyone involved, is that the epilepsy patients
- 13:55we work with have types of epilepsy where different
- 13:57ion channels or brain proteins are mutated. Because
- 14:00those proteins malfunction, brain activity is
- 14:03dysregulated. That mutation information stays
- 14:06in the stem cells and transfers into the mini
- 14:09-brains. So when we apply the venom or peptides
- 14:11we think might help treat epilepsy, We can see
- 14:14the changes in the mini brain that are specific
- 14:16to that mutation for those patients. That is
- 14:20wonderful. It avoids using animals. Ethically,
- 14:24fantastic. And it's very specific because these
- 14:27are cells from patients who already have those.
- 14:30Exactly. To be honest, eventually we will need
- 14:32animals. But the goal is to find the best peptide
- 14:35while using as few animals as possible. So first
- 14:38everything is in vitro. We do lots of analyses
- 14:41with the cells. Move on to these organoids. and
- 14:43eventually we would go to animals. And have you
- 14:47isolated any promising peptides or molecules,
- 14:50ones that have shown encouraging results for
- 14:53epilepsy? As I was saying, the epilepsy project
- 14:55is quite large. We have one peptide that has
- 14:58shown very positive results in these organoids
- 15:00and also in animal models. That part of the project
- 15:04is the most advanced. So yes, we have a very
- 15:07interesting peptide for a very specific mutation
- 15:09in sodium channels. We are now broadening the
- 15:12venom screening for other mutations in other
- 15:14channels linked to different types of epilepsy.
- 15:17In general, the epilepsy project began only recently,
- 15:20so we've been moving it forward this year. I
- 15:23can give you examples from other diseases where
- 15:25the main spider venom component has been successful.
- 15:28Australia is home to the world's most venomous
- 15:31spider, the Australian funnel -web spider. From
- 15:34the venom of one funnel -web species in Queensland,
- 15:36a peptide called Hi1a was discovered. and it
- 15:39is very promising for stroke. It was first studied
- 15:42for stroke and later progressed to heart attack
- 15:44research. This peptide is fascinating. It helps
- 15:48rescue cells that have been damaged by a heart
- 15:50attack or a cerebrovascular accident. What the
- 15:53peptide does, its mechanism, is to protect the
- 15:56cell under the conditions that occur during a
- 15:58stroke or an infarction. Based on this peptide,
- 16:01my supervisor, Professor Glenn King, founded
- 16:03a Queensland -based pharmaceutical company called
- 16:06Infensa Bioscience to produce peptides like this
- 16:08one. It is also important for heart transplantation.
- 16:11There have been positive results there. And through
- 16:14protein engineering inspired by the funnel web
- 16:16peptide, even better peptides have been produced.
- 16:19All of this you are telling us is incredibly
- 16:22complex, right? And it's fascinating to think
- 16:25it all starts with going out to find spiders
- 16:28in their habitat and seeing what their venoms
- 16:31can do. Tell us roughly what that field word
- 16:34is like and whether there is any way to know
- 16:37if the venom of one spider species might have
- 16:40more potential than another venomous species.
- 16:43Well, first, really, before going into the field,
- 16:45you have to read a lot, like everything in science.
- 16:48Pure reading. You have to learn about the spiders
- 16:51in the area, what is known about their natural
- 16:53history, and if there's anything about their
- 16:55venoms. Then, in my specific case, I've gone
- 16:58to the field several times here in Australia
- 17:00to look for the funnel web spider. The species
- 17:03we're most interested in lives on an island,
- 17:05the largest sand island in the world. There,
- 17:08instead of soil or regular sediment, you have
- 17:10sand. We go look for the entrance of the little
- 17:13burrow and start digging until we find the spider.
- 17:15Then we can bring those spiders back to the lab.
- 17:18A lot of it is trial and error, honestly. Many
- 17:21times there's no information on the spider so
- 17:23we say, well let's test the venom and see what
- 17:26comes out. and sometimes very interesting things
- 17:28appear, sometimes not. But yes, I'm particularly
- 17:31interested in Australian spiders because in Australia
- 17:34everything is weird, all the animals are weird,
- 17:37and super interesting. They all have their own
- 17:39superpower. Since Australia is an island, they've
- 17:42evolved that way. There's also something interesting
- 17:45here. There are many venomous animals, so many.
- 17:48People say that in Australia everything tries
- 17:50to kill you, right Linda? I work with spider
- 17:53venoms, but I have colleagues who work with tick
- 17:55saliva. caterpillar venoms, plants, jellyfish.
- 17:58All those different venomous organisms are super
- 18:01interesting, not only from the viewpoint of making
- 18:03medicines, but also from a purely biological
- 18:06perspective. With all that excitement in your
- 18:09life, now I feel jealous. Let's talk about your
- 18:12journey from Costa Rica to Australia. What has
- 18:15been the biggest obstacle you have faced as a
- 18:17Latin American woman and as a scientist? Something
- 18:21you would like to say has definitely been hard
- 18:25and how have you managed to overcome it? Yes,
- 18:28not everything is sunshine and roses. Like anyone
- 18:31who has migrated, there are always difficulties.
- 18:34When I left Costa Rica, I came in January 2020
- 18:37and I didn't know a pandemic was coming. Nobody
- 18:40did. I ended up on the other side of the world,
- 18:43in the middle of COVID, without my family and
- 18:46without knowing anyone. That was one of the first
- 18:48challenges. Then there's the English. I speak
- 18:51English and have spoken it since I was very small,
- 18:54but Australian English is on another level. At
- 18:57first in meetings I'd tell my friends, I don't
- 18:59know if it's the English or the science, I'm
- 19:02not sure what I'm not understanding. And it's
- 19:04not just understanding, it's communicating. In
- 19:07Spanish I can be very fluent and use flashy words,
- 19:10whatever. In English I go, how do you say that?
- 19:14Sometimes I even forget the word in Spanish.
- 19:16I have to write down what I want to say. I always
- 19:19tell people. If you only knew how smart I am
- 19:22in Spanish, I'm smarter in Spanish. The culture
- 19:25is different. I think in general we Latin Americans
- 19:28share many things in common, so we could all
- 19:31say, oh yes, that happens in my country. Here
- 19:34everything is very different. Many things are
- 19:36different, though many are great, like being
- 19:38able to walk alone, safely, in the early hours
- 19:41of the morning. I could leave the lab at 1am
- 19:44and walk home. Cultural differences are many.
- 19:47So yes, as a migrant, everyone goes through that.
- 19:50As a woman scientist, something that always strikes
- 19:53me, and maybe this isn't just in Australia, is
- 19:56that science still seems to be a man's world.
- 19:58No offense, Daniel. None taken. That's the truth.
- 20:02Most senior positions are still held by men.
- 20:05Almost all my collaborations were with men. So
- 20:08sometimes I'd have to present things in a meeting,
- 20:10say on Zoom, with collaborators. They were all
- 20:13men, all white, native English speakers, some
- 20:16Australian, some American, and it was impossible
- 20:18not to feel intimidated, despite the fact that
- 20:21they're wonderful people. My advisors too, both
- 20:24my PhD and postdoc supervisors are men, are great
- 20:27human beings and brilliant scientists, but that
- 20:30didn't stop me from feeling intimidated. I'd
- 20:32tell myself, I have a meeting with six men, all
- 20:35speaking perfect English, perfect science, and
- 20:38I felt I had to prepare, have a little tea beforehand,
- 20:41and the meetings always went fine. They're really
- 20:43nice, pura vida, as we say in Costa Rica. When
- 20:46I noticed that, I tried to seek other collaborations.
- 20:49Honestly, I found a few. Of course there are
- 20:52other women in science, so we worked with them.
- 20:55I always tried to have at least one woman on
- 20:57my PhD committee. I specifically asked for that.
- 21:00As for English, I'm still working on it. My partner
- 21:03is Australian, so although we can speak Spanish,
- 21:06we always communicate in English and he helps
- 21:08me with words and phrasing. Reading a lot in
- 21:11English helps. and encouraging other women too,
- 21:13it can be done. It's curious that the top positions
- 21:16are still mostly male, even though there are
- 21:19many women in science. When I hear that, I say,
- 21:22I'll stay here longer to prove it's possible.
- 21:24I also got involved in outreach. During my PhD
- 21:28I was a science ambassador for the institute,
- 21:30explaining science, going to schools, talking
- 21:33about spiders, I could talk about spiders all
- 21:35day. It's about showing the world that someone
- 21:38from a developing country can do it too. And
- 21:41to finish up, the diseases you say could be treated
- 21:43with these compounds have a very high impact
- 21:46on the patient's life quality. How do you think
- 21:49it impacts patients to have people researching
- 21:52and developing this treatment? These diseases,
- 21:54neurological and cardiac, severely affect patients'
- 21:58quality of life. As I said, this is a huge project
- 22:01and interdisciplinarity is vital. We work with
- 22:03many researchers across Australia, with clinical
- 22:06specialists, and something I find very interesting.
- 22:09with NGOs. The epilepsy -related NGOs in Australia
- 22:13and the US were founded mainly by parents of
- 22:15children with epilepsy. So you learn not only
- 22:18the science but also the emotional and physical
- 22:20burdens of living with epilepsy. Epilepsy affects
- 22:23a million people worldwide, and not all forms
- 22:26have treatments. Some are very severe. The spectrum
- 22:29is huge. Pediatric epilepsies can hinder development.
- 22:33We usually think of seizures, but behind them
- 22:36can be cognitive delays. Some patients don't
- 22:39live long lives, and there's a heavy emotional
- 22:41load. My hope is that by designing these therapies,
- 22:44we can make epilepsy more manageable, targeting
- 22:46forms with no treatment, with fewer side effects,
- 22:49helping patients day to day, and also easing
- 22:52the burden on their families. Dani, what you
- 22:55do is awesome. Thanks for sharing all your experiences,
- 22:58challenges, and knowledge in simple words. Thank
- 23:02you. This episode was inspired by the web that
- 23:04connects us with our natural world. Despite myths
- 23:07and stigmas, when we look beyond fear, we find
- 23:11ancient astonishing animals that teach us about
- 23:14adaptation and resilience. Our journey with Dani
- 23:18urges us to see past myths, the unknown, and
- 23:21fear, always guided by curiosity. Of the more
- 23:25than 53 ,000 described spider species, only 25
- 23:29pose a real risk to humans. This means less than
- 23:330 .05%. making widespread fear a disproportionate
- 23:38myth. Their venoms, on the other hand, have yielded
- 23:42more than 1 ,600 peptides with therapeutic potential,
- 23:47and millions more may await discovery, ready
- 23:50to ease pain, to stop arrhythmias, or protect
- 23:53hearts, like the promising HI1A peptide from
- 23:57the Australia funnel web spider. But venom isn't
- 24:00their only superpower. For 380 million years,
- 24:05Spiders have been invisible guardians of balance,
- 24:08devouring up to 800 million tons of prey each
- 24:11year, controlling pests and recycling nutrients.
- 24:15In their smallness, they teach us resilience
- 24:18and efficiency, virtues as valuable for nature
- 24:22as for medicine. Science Behind the Glass is
- 24:24an independently produced and edited podcast
- 24:27by hosts Linda Hernandez -Duran and Daniel Sguerra.
- 24:30with invaluable technical support from Rafael
- 24:33Giordano and original music by our colleague
- 24:35and friend Bernardo Aguilar. Follow us on Instagram,
- 24:38X, Facebook, LinkedIn, and TikTok. And visit
- 24:41our website for more stories, resources, and
- 24:44updates. If this episode inspired you, share
- 24:48it with your communities and your friends. And
- 24:50consider supporting us via PayPal in the button
- 24:53Support Us in our webpage. Your contribution
- 24:57will help these narratives keep growing. Remember...
- 25:00Innovation is born where wonders meet curiosity,
- 25:03and sometimes where a tiny spider waits in its
- 25:07way. Until next time.